1933 Industries Reports Second Quarter 2023 Financial Results and Announces Ester Vigil as President
1933 Industries Reports Second Quarter 2023 Financial Results and Announces Ester Vigil as President
VANCOUVER, BC / ACCESSWIRE / April 3, 2023 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCQB:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce its second quarter financial results ("Q2 2023") For the six months ended January 31, 2023, and 2022. All amounts expressed are in Canadian dollars.
不列颠哥伦比亚省温哥华/ACCESSWIRE/2023年4月3日/1933工业公司(以下简称“公司”或“1933工业公司”)(CSE:TGIF)(场外交易市场代码:TGIFF)是一家专注于内华达州的大麻种植和生产商,该公司高兴地宣布了截至2023年1月31日和2022年1月31日的六个月的第二季度财务业绩(“2023年第二季度”)。所有金额均以加元表示。
The Company owns 91% of Alternative Medicine Association (AMA), the Company's cultivation and production subsidiary focused on the medical and adult-use cannabis market, and 100% of CBD product manufacturer Infused MFG LLC (Infused). The Company's revenue is derived from wholesale cannabis sales in Nevada (AMA), and from the sale of hemp-derived consumer packaged goods (Infused) under the Canna Hemp brand sold across the US via e-commerce at cannahemp.com.
该公司拥有替代医学协会(AMA)91%的股份,AMA是公司专注于医用和成人用大麻市场的种植和生产子公司,以及CBD产品制造商Infed MFG LLC的100%股份。该公司的收入来自内华达州(AMA)的大麻批发销售,以及美人掌大麻下大麻衍生消费包装商品(注入)的销售该品牌通过canahemp.com上的电子商务在美国各地销售。
Q1 2023 Financial Highlights
2023年第一季度财务亮点
- Revenue $3.6 million for Q2 2023 and $9.2 million for the six months ended January 31, 2023
- Expenses $0.2 million
- Gross margin $1.9 million before adjustments
- Net loss $0.4 million
- Adjusted EBITDA $0.1 million - Second consecutive quarter of positive EBITDA
- 2023年第二季度收入360万美元,截至2023年1月31日的6个月收入920万美元
- 支出20万美元
- 调整前毛利率为190万美元
- 净亏损40万美元
- 调整后的EBITDA为10万美元-连续第二个季度EBITDA为正
Consolidated Operating Highlights
综合运营亮点
- Total revenues were $3.6 million for Q2 2023, representing a 13% increase over $3.2 million for Q2 2022. Revenues are $9.2 million for the six months ended January 31, 2023, representing a 52% increase from $6.0 million during the same period in 2022.
- Expenses of $0.2 million for Q2 2023 decreased by 92% from $2.4 million in Q2 2022 in large part due to a substantial tax refund from the IRS. The Company continues to work diligently on controlling expenses.
- Gross margin was $1.9 million, before fair value adjustments on biological assets and realized fair value adjustments on the sale of inventory. The decrease in gross margin is attributable to a decrease in flower pricing in Nevada.
- Net loss was $0.4 million for Q2 2023 and $0.8 million for Q2 2022.
- Adjusted EBITDA was $0.1 million for Q2 2023 and $0.1 million for Q2 2022.
- Cash at the end of the period was $2.9 million compared to $0.8 million during the same period in 2022.
- 2023年第二季度总收入为360万美元,比2022年第二季度的320万美元增长13%。截至2023年1月31日的6个月,收入为920万美元,比2022年同期的600万美元增长了52%。
- 2023年第二季度的支出为20万美元,较2022年第二季度的240万美元下降了92%,这在很大程度上是由于美国国税局的大量退税。公司将继续努力控制开支。
- 在生物资产公允价值调整和出售存货实现公允价值调整之前,毛利率为190万美元。毛利率的下降归因于内华达州鲜花价格的下降。
- 2023年第二季度净亏损40万美元,2022年第二季度净亏损80万美元。
- 2023年第二季度调整后的EBITDA为10万美元,2022年第二季度为10万美元。
- 期末现金为290万美元,而2022年同期为80万美元。
Management Commentary
管理评论
Mr. Paul Rosen, Chairman and CEO of 1933 Industries commented, "Wholesale pricing pressure continues to impact cultivators in Nevada, with lower sale prices on cannabis products experienced across the industry. In addition, the Company has chosen to deal with some legacy infrastructure issues that compressed our overall capacity this quarter. During the reporting period, the Company continued to focus on strengthening its operation. Necessary and essential infrastructure improvements to the Company's cultivation facility, including improvements to the facility's irrigation, air movement and humidification systems have been initialized and are well underway. A build-up of inventory will be the Company's priorities in the following quarters in order to increase the production of sellable dried flower and pre-rolls. We expect flower prices to stabilize in the near future, and we expect as well that the launch of consumption lounges will create a new attraction for visitors to the state and expand cannabis-related tourism. The Company is well positioned to benefit from increased demand, flower price stabilization, and the strength of its top brand and in-demand products that deliver excellent value to consumers.
1933工业公司董事长兼首席执行官保罗·罗森先生评论说:“批发价格压力继续影响着内华达州的种植者,整个行业的大麻产品销售价格都较低。此外,该公司选择处理一些遗留的基础设施问题,这些问题压缩了我们本季度的整体产能。在本报告所述期间,公司继续专注于加强运营。对公司种植设施的必要和必要的基础设施改进,包括对设施的灌溉、空气流动和加湿系统的改进已经启动并正在顺利进行。增加库存将是该公司在接下来几个季度的优先事项,以增加可销售的干花和预卷的产量。我们预计鲜花价格将在不久的将来稳定下来,我们还预计消费休息室的推出将为该州的游客创造一个新的吸引力,并扩大与大麻相关的旅游业。该公司处于有利地位,受益于需求的增加、花卉价格的稳定以及其顶级品牌和需求旺盛的产品的实力,这些产品为消费者带来了极好的价值。
Operationally, the Company has made substantial improvements in lowering its debt load, reducing expenses, and conserving its working capital over the last several quarters. The Company recorded positive Adjusted EBITDA for a second quarter in a row, a milestone in the Company's history."
在运营方面,该公司在过去几个季度在降低债务负担、减少开支和节省营运资本方面取得了重大改进。公司连续第二个季度录得调整后EBITDA为正数,这是公司历史上的一个里程碑。“
Appointment of Ester Vigil as President
任命维吉尔为总裁
The Company is pleased to announce that Ms. Ester Vigil has been appointed as President. Ms. Vigil previously held the role of Director of Sales and served as president from 2019 to 2020. Ms. Vigil's return to the Company has been marked by significant achievements, including repositioning AMA as a top brand in Nevada. "Ester's contributions to the Company are very meaningful," said Mr. Rosen. "She has added value in all areas of our business, and her leadership has earned her esteem and respect from both her colleagues at 1933, and throughout the overall Nevada cannabis industry. I look forward to Ester continuing to help improve our business, deliver excellent value to our customers and deliver future growth."
本公司高兴地宣布,Ester Vigil女士已被任命为总裁。维吉尔女士此前担任董事销售部职务,并于2019年至2020年担任总裁。Vigil女士重返公司取得了重大成就,包括将AMA重新定位为内华达州的顶级品牌。罗森先生说:“埃斯特公司对公司的贡献非常有意义。她在我们业务的所有领域都增加了价值,她的领导能力赢得了她在1933年的同事以及整个内华达州大麻行业的尊重和尊重。我期待埃斯特继续帮助改善我们的业务,为我们的客户提供卓越的价值,并实现未来的增长。
Financial statements are prepared in accordance with International Financial Reporting Standards. Detailed information regarding the Company's financial results as well as management's discussion and analysis can be found at and
财务报表是根据国际财务报告准则编制的。有关公司财务业绩以及管理层的讨论和分析的详细信息,请访问和
Please note the next financial release dates in accordance with the continuous disclosure schedule set out by the British Columbia Securities Commission:
请注意,根据不列颠哥伦比亚省证券委员会制定的持续披露时间表,下一次财务发布日期:
2023 Financial Release Dates | |
Reporting Quarter | Release Date |
Q3/2023 | June 29, 2023 |
Q4/YE 2023 | November 28, 2023 |
Q1/2024 | January 1, 2024 |
Q2/2024 | April 2, 2024 |
Q3/2024 | July 2, 2024 |
Q4/YE 2024 | November 28, 2024 |
2023年财务发布日期 | |
报告季度 | 发布日期 |
2023年第三季度 | 2023年6月29日 |
2023年第4季度 | 2023年11月28日 |
2024年第一季度 | 2024年1月1日 |
2024年第二季度 | 2024年4月2日 |
2024年第三季度 | 2024年7月2日 |
2024年第4季度 | 2024年11月28日 |
About 1933 Industries Inc.
关于1933工业公司
1933 Industries is a Nevada-based, growth-orientated company, focusing on the cultivation and manufacturing of a large portfolio of cannabis consumer-packaged goods in a variety of formats for both the wholesale and retail markets. Its product offerings include: THC flower, pre-rolls, and extracted products under the AMA and Level X brands for the Nevada market; Canna Hemp, national cannabidiol (CBD) brand of infused wellness products including tinctures, gummies, topicals and sport recovery products. The Company owns 91% of Alternative Medicine Association, LC (AMA) and 100% of Infused MFG LLC (Infused).
1933 Industries是一家总部位于内华达州、以增长为导向的公司,专注于为批发和零售市场种植和制造各种形式的大麻消费品组合。该公司提供的产品包括:面向内华达州市场的AMA和Level X品牌的THC鲜花、预卷和提取产品;美人掌、国家大麻二醇(CBD)品牌的灌注型保健产品,包括药酒、口香糖、外用药品和运动康复产品。该公司拥有替代医学协会LC(AMA)91%的股份和INFINED MFG LLC(INFUSED)100%的股份。
About Alternative Medicine Association
关于替代医学协会
AMA is a licensed medical and adult-use cannabis cultivation and extraction subsidiary that produces its own branded line of unique cannabis products. AMA's extensive menu of cannabis products include: craft cannabis flower, pre-rolls, full spectrum oils, high quality distillates, proprietary blends of terpenes, vaporizer products and boutique concentrates such as shatter, crumble, batter, sugar wax, diamonds, and live resin. Ultra-craft brand Level X is an exclusive collection of exotic strains, selected specifically for their distinctive terpene profiles, high THC levels, and flavonoids. With state-of-the-art cultivation and extraction facilities based in Las Vegas, Nevada, AMA seeks to offer medical patients and recreational users alike a cannabis experience that's exceptional, potent, and consistent in quality.
AMA是一家获得许可的医疗和成人用大麻种植和提取子公司,生产自己的独特大麻产品品牌系列。AMA的大麻产品种类繁多,包括:工艺大麻花、预卷、全光谱油、高品质馏分、专有的萜烯混合物、蒸发产品和精品浓缩物,如碎、碎、面糊、糖蜡、钻石和活树脂。超级工艺品牌Level X是外来菌株的独家收藏,特别是因为它们独特的萜类特征、高THC水平和黄酮类化合物而被挑选出来。凭借位于内华达州拉斯维加斯的最先进的种植和提取设施,AMA寻求为医疗患者和娱乐用户提供非凡、有效和质量一致的大麻体验。
AMA is also licensed in Nevada as an adult-use cannabis distributor.
AMA还在内华达州获得了成人用大麻经销商的许可。
About Canna Hemp
关于美人掌大麻
With over 60 products in its portfolio, the Canna Hemp brand offers products in a variety of verticals and consumption formats, including, effects-based tinctures, topicals, vape pens and cartridges, gummies, and capsules for Sleep, Relief, Calm, Focus and Energy. High-grade CBD and a proprietary blend of terpenes formulated for specific effects are key differentiators for the Canna Hemp line. The Company recently introduced previously untapped cannabinoids Cannabigerol (CBG) and Cannabinol (CBN) to its portfolio of products with a new line of natural tinctures and gummies.
美人掌大麻品牌在其产品组合中拥有60多种产品,提供各种垂直和消费形式的产品,包括基于效果的酊剂、外用药物、蒸汽笔和弹药筒、口香糖和睡眠、舒缓、镇静、专注和能量胶囊。高级CBD和为特定效果而配制的专有萜烯混合物是美人掌大麻系列的关键区别。该公司最近在其产品组合中引入了以前未开发的大麻酚(CBG)和大麻酚(CBN),并推出了一系列新的天然酊剂和胶水。
For further information please contact:
Alexia Helgason, VP, IR, Marketing, Media
604-728-4407
欲了解更多信息,请联系:
阿列克西亚·赫尔加森,媒体市场营销副总裁
604-728-4407
alexia@1933industries.com
Paul Rosen, CEO
paul@1933industries.com
邮箱:alexia@1933Industrial es.com
保罗·罗森,首席执行官
邮箱:Paul@1933Industrial es.com
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
加拿大证券交易所及其监管服务提供商(该术语在加拿大证券交易所的政策中定义)均不对本新闻稿的充分性或准确性承担责任。
Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on . 1933 Industries undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.
有关前瞻性陈述的通知:本新闻稿包含前瞻性陈述。使用“预期”、“继续”、“估计”、“预期”、“可能”、“将”、“项目”、“应该”、“相信”和类似词语中的任何一个都是为了识别前瞻性陈述。尽管公司认为前瞻性陈述所基于的预期和假设是合理的,但不应过度依赖前瞻性陈述,因为公司不能保证它们将被证明是正确的。由于前瞻性陈述涉及未来的事件和情况,它们本身就具有内在的风险和不确定性。这些陈述仅代表本新闻稿发布之日的情况。由于许多因素和风险,包括公司披露文件中讨论的各种风险因素,实际结果可能与目前预期的大不相同,这些因素和风险可以在公司简介中找到。除非法律要求,否则工业公司不承担公开更新或修改任何前瞻性信息的义务,无论是由于新信息、未来事件还是其他原因。
SOURCE: 1933 Industries Inc.
资料来源:1933年工业公司